Onos, ROMVIMZA

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight

07.08.2025 - 18:04:41 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | boerse | 67918944 |